Term ends Mar 12, 2028 · High confidence
20-year base term ends Mar 12, 2028
Held by 23andMe Genomics LLC
Filed Aug 27, 2020 as application 17/004,911 · Granted Jan 19, 2021
Base term, 20 years from filing
Today
2008
2028
Clock starts
Mar 12, 2008
Mar 12, 2008
Term ends
Mar 12, 2028
Mar 12, 2028
Granted
Jan 19, 2021
Jan 19, 2021
base term
fee events
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 10,803,134, US 10,957,455, to Mar 12, 2028. The term already ends on or before that date, so the cap shortened nothing.
1 of 1
Maintenance fees paid
One maintenance fee can end this term early, the one due 3.5 years from grant; the next one's grace period runs past the term end. This counts it if the record shows it paid.
20
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 1 of 1 maintenance fees is paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Mar 12, 2008, when application 12/047,203, the earliest non-provisional in its chain, was filed (this one was filed Aug 27, 2020) | Mar 12, 2028 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 10,803,134, US 10,957,455) | resolves to Mar 12, 2028, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 1 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Mar 12, 2028 | High confidence |
This family
| Application 12/047,203 | Abandoned not computed | not computed |
| Application 14/822,023 | Abandoned not computed | not computed |
| US 10,803,134 | In force Sep 2028 | Sep 2028 |
| US 10,957,455 | In force Mar 2028 | Mar 2028 |
| US 10,896,233 | this patent Mar 2028 | Mar 2028 |
| US 11,545,269 | In force Aug 2028 | Aug 2028 |
| US 11,348,691 | In force Mar 2028 | Mar 2028 |
| US 11,348,692 | In force Mar 2028 | Mar 2028 |
8 of 20 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Aug 27, 2020 Reel 53621, frame 17 | Kenedy, Andrew A.; Eldering, Charles A. | Expanse Networks, Inc. | Assignment of Assignor's Interest |
| Aug 27, 2020 Reel 53625, frame 395 | Expanse Networks, Inc. | Expanse Bioinformatics, Inc. | Change of Name |
| Apr 5, 2021 Reel 55824, frame 964 | Expanse Bioinformatics, Inc. | Expanse Bioinformatics, Inc. | Change of Address by Assignee |
| Jan 5, 2022 Reel 58554, frame 21 | Expanse Bioinformatics, Inc. | 23andMe, Inc. | Assignment of Assignor's Interest |
| Jan 7, 2022 Reel 58982, frame 739 | Expanse Bioinformatics, Inc. | 23andMe, Inc. | Corrective Assignment to Correct the Assignee Address Previously Recorded at Reel: 058554 Frame: 0021. Assignor(S) Hereby Confirms the Assignment . |
| Aug 26, 2025 Reel 72562, frame 795 | 23andMe, Inc. | 23andMe PGS LLC | Assignment of Assignor's Interest |
| Oct 22, 2025 Reel 73168, frame 531 | 23andMe PGS LLC | 23andMe Genomics LLC | Change of Name |
| Jan 6, 2026 Reel 74434, frame 334 | 23andMe PGS LLC | 23andMe Genomics LLC | Corrective Assignment to Correct the App. No. 63806415 to 63806145 and Appl No. 17721779 to 17731779 Previously Recorded on Reel 73168 Frame 531. Assignor(S) Hereby Confirms the Change of Name. |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Mar 2028
Term ends Mar 12, 2028. No further fees fall due before then
Terminal disclaimer
A terminal disclaimer resolved from the filed document, referencing US 10,803,134, US 10,957,455, ends no earlier than this term, so it caps nothing.
Citations
44
later US patents cite this one
That is top 5% of utility patents granted in 2021 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.